Mingzhen Yang

558 total citations
26 papers, 317 citations indexed

About

Mingzhen Yang is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Mingzhen Yang has authored 26 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Mingzhen Yang's work include Autophagy in Disease and Therapy (7 papers), Cancer Mechanisms and Therapy (4 papers) and Cancer-related molecular mechanisms research (3 papers). Mingzhen Yang is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Cancer Mechanisms and Therapy (4 papers) and Cancer-related molecular mechanisms research (3 papers). Mingzhen Yang collaborates with scholars based in China, United States and Canada. Mingzhen Yang's co-authors include Qingshu Zeng, Ruixiang Xia, Jiqin Lian, Christopher M. Spring, Pingguo Chen, Dianne E. van der Wal, Heyu Ni, Elisa Simpson, Lingjie Zhang and Lingyan Zhu and has published in prestigious journals such as PLoS ONE, Science Advances and Cell Death and Differentiation.

In The Last Decade

Mingzhen Yang

26 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingzhen Yang China 9 144 93 56 52 50 26 317
Inês Mota Portugal 11 125 0.9× 91 1.0× 16 0.3× 46 0.9× 48 1.0× 21 382
Jae Hoo Park South Korea 9 145 1.0× 61 0.7× 25 0.4× 21 0.4× 30 0.6× 20 286
Diederik van Bodegom United States 7 185 1.3× 40 0.4× 28 0.5× 42 0.8× 42 0.8× 10 360
Li Weng United States 11 312 2.2× 129 1.4× 37 0.7× 77 1.5× 77 1.5× 21 514
Jing Ling China 10 115 0.8× 79 0.8× 26 0.5× 18 0.3× 61 1.2× 48 287
Ivana Frech United States 5 233 1.6× 79 0.8× 24 0.4× 39 0.8× 70 1.4× 12 296
Ling Sun China 11 201 1.4× 81 0.9× 21 0.4× 19 0.4× 118 2.4× 19 338
Irina Mantovani Italy 8 291 2.0× 74 0.8× 20 0.4× 30 0.6× 38 0.8× 10 381
M. Georget France 5 78 0.5× 74 0.8× 37 0.7× 40 0.8× 22 0.4× 6 287

Countries citing papers authored by Mingzhen Yang

Since Specialization
Citations

This map shows the geographic impact of Mingzhen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzhen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzhen Yang more than expected).

Fields of papers citing papers by Mingzhen Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzhen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzhen Yang. The network helps show where Mingzhen Yang may publish in the future.

Co-authorship network of co-authors of Mingzhen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzhen Yang. A scholar is included among the top collaborators of Mingzhen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzhen Yang. Mingzhen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Ming, Dong Liu, Lingxi Chen, et al.. (2025). Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy. Cell Death and Differentiation. 32(9). 1630–1647. 1 indexed citations
2.
He, Ming, Di Wu, Ping Zheng, et al.. (2024). Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Hepatology Communications. 8(4). 7 indexed citations
3.
He, Haiyan, Ming He, Haojun Xiong, et al.. (2024). Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway. Experimental Cell Research. 439(1). 114094–114094. 1 indexed citations
4.
5.
Yang, Mingzhen, et al.. (2024). The role of Lactobacillus plantarum in oral health: a review of current studies. Journal of Oral Microbiology. 16(1). 2411815–2411815. 2 indexed citations
6.
7.
Sun, Ying, Yanyan Ma, Panpan Xue, et al.. (2024). Metal ions-anchored bacterial outer membrane vesicles for enhanced ferroptosis induction and immune stimulation in targeted antitumor therapy. Journal of Nanobiotechnology. 22(1). 474–474. 14 indexed citations
8.
Zeng, Rong, Meng He, Xufang Dai, et al.. (2024). Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect. Biochemical Pharmacology. 227. 116419–116419. 6 indexed citations
9.
Yang, Mingzhen, Meng He, Xiang Li, et al.. (2024). KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. Cancer Letters. 584. 216598–216598. 17 indexed citations
10.
He, Meng, Dong Liu, Xufang Dai, et al.. (2023). Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells. Biochemical Pharmacology. 211. 115538–115538. 5 indexed citations
11.
Chen, Rui, Peng Li, Yan Fu, et al.. (2023). Chaperone-mediated autophagy promotes breast cancer angiogenesis via regulation of aerobic glycolysis. PLoS ONE. 18(3). e0281577–e0281577. 11 indexed citations
12.
Xiao, Hanxi, Yaran Wu, Dongjing Yan, et al.. (2023). CircPHKB decreases the sensitivity of liver cancer cells to sorafenib via miR-1234-3p/CYP2W1 axis. Genomics. 116(1). 110764–110764. 2 indexed citations
13.
Zhang, Teng, Jun Li, Fang Yuan, et al.. (2023). Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer. Cancer Genetics. 276-277. 48–59. 8 indexed citations
14.
Xiong, Haojun, Xufang Dai, Xiaojing Yan, et al.. (2022). Deacetylation of ATG4B promotes autophagy initiation under starvation. Science Advances. 8(31). eabo0412–eabo0412. 30 indexed citations
15.
Yan, Xiaojing, Xufang Dai, Chen Huang, et al.. (2021). Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells. Experimental Cell Research. 406(1). 112755–112755. 13 indexed citations
16.
Hong, Jian, et al.. (2020). LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders. International Journal of Hematology. 111(6). 851–857. 2 indexed citations
17.
Li, Qingsheng, Linjie Zhang, Ruixiang Xia, et al.. (2015). Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment. Medical Principles and Practice. 24(5). 458–464. 13 indexed citations
18.
19.
Chen, S, Qi Han, Mingzhen Yang, et al.. (2013). IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway. Cell Death and Disease. 4(10). e842–e842. 40 indexed citations
20.
Zeng, Qingshu, Lingyan Zhu, Lili Tao, et al.. (2011). Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti‐platelet GPIIbIIIa versus GPIbα antibodies. American Journal of Hematology. 87(2). 206–208. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inês Mota Breakdown of academic impact, for papers by Jae Hoo Park Breakdown of academic impact, for papers by Diederik van Bodegom Breakdown of academic impact, for papers by Li Weng Breakdown of academic impact, for papers by Jing Ling Breakdown of academic impact, for papers by Ivana Frech Breakdown of academic impact, for papers by Ling Sun Breakdown of academic impact, for papers by Irina Mantovani Breakdown of academic impact, for papers by M. Georget
Rankless by CCL
2026